Antipsychotic-induced metabolic disturbances receive little attention among Medicaid patients treated with second-generation drugs, according to an analysis of more than 100,000 cases.
More >> Metabolic Tests Ignored in Medicaid Patients on Antipsychotics
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment